Filing search / Ownership / Epizyme, Inc. / Page 2

SC 14D9/A

4z04dqu05w4 o0azdpm

12 Aug 22

Tender offer solicitation (amended)

7:51am

SC TO-T/A

9lxc0jwbbs5 d3w

12 Aug 22

Third party tender offer statement (amended)

7:44am

8-K

e3tayp0kpf

9 Aug 22

Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update

7:12am

SC TO-T/A

lmqqy

5 Aug 22

Third party tender offer statement (amended)

8:14am

SC 14D9/A

gqamd5 ex0v5it84pue1

5 Aug 22

Tender offer solicitation (amended)

8:05am

S-8

a1m3w

4 Aug 22

Registration of securities for employees

4:08pm

SC TO-T/A

19ghys 0dn

1 Aug 22

Third party tender offer statement (amended)

5:24pm

SC 14D9/A

m0aj8c

1 Aug 22

Tender offer solicitation (amended)

5:06pm

SC 14D9

rjhqg r7edtn

12 Jul 22

Tender offer solicitation

8:37am

SC TO-T

29hroi88a5sv w16

12 Jul 22

Third party tender offer statement

8:25am

SC TO-C

bdoeog8

5 Jul 22

Information about tender offer

5:10pm

SC TO-C

mzdw1l4h3s6tv1d43

27 Jun 22

Information about tender offer

6:35am

SC14D9C

j122u7qvx fzrt67vr

27 Jun 22

Written communication relating to third party tender offer

6:21am

8-K

mbpki56pe51

27 Jun 22

Ipsen to acquire Epizyme, expanding its portfolio in oncology

6:14am

8-K

ehkce1ccpy2jmj

24 May 22

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:38pm

8-K

t79f8e4uf6

19 May 22

Departure of Directors or Certain Officers

7:57am

8-K

fpljcfx1odhu

10 May 22

Epizyme Reports First Quarter 2022 Financial Results and Provides Business Update

7:09am

CT ORDER

mlyrdi1w

3 May 22

Confidential treatment order

4:55pm